ABSTRACT
Decisions to adhere to health-protective behaviors (e.g. mask-wearing, social distancing, etc.) that impact the spread of COVID-19 are not made in isolation by each individual. They are instead the result of the social construction of perceived risks and resulting community norms. In populations in which disease is unlikely to spread throughout all communities simultaneously, community-driven perception of risk can drastically alter collective outcomes. A community could respond to a few infections by becoming fearful and adopting anticipatory behaviors that protect them from disease spread. Similarly, there could be false reassurance, in which low disease incidence over time leads to community consensus that protective actions are unnecessary (even if they are the reason cases remains rare). We therefore model COVID-19 spread with three synergistic dynamics governing individual behavioral choices: (1) Social construction of concern, (2) Awareness of disease incidence, and (3) Reassurance by lack of disease. We use a multiplex network approach that captures social communication and epidemiological spread. We find that effective protective policies enacted too early may backfire by allowing a community to become reassured and therefore unwilling to adopt or maintain further protective behaviors. Based on these insights, we propose that public health policies for which success relies on collective action should be designed to exploit the behaviourally receptive phase; the period between the generation of sufficient concern as to foster adoption of novel protective behaviors and the relaxation of adherence driven by reassurance fostered by avoidance of negative outcomes over time.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by NSF DEB 2028710.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
NA
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes